A randomized clinical trial shows that only 13% of people discontinued semaglutide compared to 27.6% for liraglutide in a 68-week trial
Only three semaglutide drugs are approved by the FDA, including Ozempic, Wegovy, and Rybelsus, while in India, the Drugs Controller General of India (DCGI) has approved only Novo Nordisk's oral semaglutide (Rybelsus)
If you are using one of these medications, you might be wondering whether combining two weight-loss drugs could offer additional benefits
Alternate Dosing Schedules : For long-term users with stable results, dosing frequency may be reduced (e.g., biweekly injections at the same dose)
Many people report noteworthy weight loss after the first 4 weeks of taking semaglutide, and they become more aware of their food intake and their body adjusts to the medication